Abstract
Androgen ablation is an effective palliative treatment of advanced carcinoma of the prostate. A variety of drugs with diverse mechanisms of action, effectiveness, and side effects are used to treat patients with this disease. This paper discusses the management of the most common side effects that result from treatment with luteinizing hormone-releasing hormone (LHRH) agonists, antiandrogens, ketoconazole, estrogens, and progestational agents. The most common side effects are loss of libido and impotence, hot flushes, gynecomastia, the flare phenomenon (LHRH agonists), nausea and vomiting, liver toxicity, and thromboembolic events (estrogens). The flare phenomenon associated with LHRH analog treatment is prevented best by pretreatment with antiandrogens or estrogens. Progestational agents can reduce hot flashes markedly. Gynecomastia may be prevented by preliminary breast irradiation. Erectile dysfunction is the most problematic side effect and possible treatments for this condition are discussed. Cancer 1995 ;75 : 1983-6.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
